日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Clinical outcomes with perioperative nivolumab by nodal status in patients with stage III resectable NSCLC: phase 3 CheckMate 77T exploratory analysis

III期可切除非小细胞肺癌患者围手术期接受纳武利尤单抗治疗的临床结局与淋巴结状态的关系:CheckMate 77T III期探索性分析

Provencio, Mariano; Awad, Mark M; Spicer, Jonathan D; Janssens, Annelies; Moiseyenko, Fedor; Gao, Yang; Watanabe, Yasutaka; Alexandru, Aurelia; Guisier, Florian; Frost, Nikolaj; Franke, Fabio; Hiltermann, T Jeroen Nicolaas; He, Jie; Tanaka, Fumihiro; Lu, Shun; Coronado Erdmann, Cinthya; Sathyanarayana, Padma; Tran, Phuong; Devas, Vipul; Cascone, Tina

Faecalibacterium prausnitzii, depleted in the Parkinson's disease microbiome, improves motor deficits in α-synuclein overexpressing mice.

帕金森病微生物组中减少的普拉梭菌(Faecalibacterium prausnitzii)可改善α-突触核蛋白过表达小鼠的运动缺陷。

Moiseyenko Anastasiya, Antonello Giacomo, Schonhoff Aubrey M, Boktor Joseph C, Long Kaelyn, Dirks Blake, Oguienko Anastasiya D, Winnett Alexander Viloria, Simpson Patrick, Daeizadeh Dorsa, Ismagilov Rustem F, Krajmalnik-Brown Rosa, Segata Nicola, Waldron Levi D, Mazmanian Sarkis K

Interconnection of Gut Microbiome and Efficacy of Immune Checkpoint Inhibitors in Inoperable Non-Small-Cell Lung Cancer

肠道微生物群与免疫检查点抑制剂在不可手术的非小细胞肺癌中的疗效之间的相互联系

Moiseenko, Fedor; Kechin, Andrey; Koryukov, Maksim; Boyarskikh, Ulyana; Gabina, Albina; Oganesian, Ani; Belukhin, Sergey; Makarkina, Maria; Elsakova, Ekaterina; Artemeva, Elizaveta; Myslik, Alexander; Volkov, Nikita; Bogdanov, Alexey; Kuligina, Ekaterina; Aleksakhina, Svetlana; Iyevleva, Aglaya; Ivantsov, Alexander; Bogdanov, Andrey; Sidorenko, Sergey; Gostev, Vladimir; Komissarov, Alexey; Dudurich, Vasilisa; Danilov, Lavrenty; Imyanitov, Evgeny; Moiseyenko, Vladimir

Baseline Radiomics as a Prognostic Tool for Clinical Benefit from Immune Checkpoint Inhibition in Inoperable NSCLC Without Activating Mutations

基线放射组学作为预测无激活突变的不可手术非小细胞肺癌患者从免疫检查点抑制剂治疗中获益的预后工具

Moiseenko, Fedor; Radulovic, Marko; Tsvetkova, Nadezhda; Chernobrivceva, Vera; Gabina, Albina; Oganesian, Any; Makarkina, Maria; Elsakova, Ekaterina; Krasavina, Maria; Barsova, Daria; Artemeva, Elizaveta; Khenshtein, Valeria; Levchenko, Natalia; Chubenko, Viacheslav; Egorenkov, Vitaliy; Volkov, Nikita; Bogdanov, Alexei; Moiseyenko, Vladimir

Phase 2 study of the antitumour activity and safety of simlukafusp alfa (FAP-IL2v) combined with atezolizumab in patients with recurrent and/or metastatic cervical squamous cell carcinoma

一项评估simlukafusp alfa (FAP-IL2v)联合atezolizumab治疗复发性和/或转移性宫颈鳞状细胞癌患者的抗肿瘤活性和安全性的II期研究

Verlingue, Loic; Italiano, Antoine; Prenen, Hans; Guerra Alia, Eva Maria; Tosi, Diego; Perets, Ruth; Lugowska, Iwona; Moiseyenko, Vladimir; Gumus, Mahmut; Arslan, Cagatay; Lindsay, Colin R; Deva, Sanjeev; Taus, Álvaro; Oaknin, Ana; Rottey, Sylvie; Cicin, Irfan; Goksu, Sema Sezgin; Smolin, Alexey; Roselló-Keränen, Susana; Habigt, Christin; Marbach, Daniel; Boetsch, Christophe; Dejardin, David; Sleiman, Nassim; Evers, Stefan; Richard, Muriel; Ardeshir, Caroline; Charo, Jehad; Kraxner, Anton; Teichgräber, Volker; Keshelava, Nino; Dziadziuszko, Rafal

Tumor alkalization therapy: misconception or good therapeutics perspective? - the case of malignant ascites

肿瘤碱化疗法:误解还是良好的治疗前景?——以恶性腹水为例

Bogdanov, Alexey; Verlov, Nikolay; Bogdanov, Andrey; Burdakov, Vladimir; Semiletov, Valeriy; Egorenkov, Vitaliy; Volkov, Nikita; Moiseyenko, Vladimir

Six-Year Survival Outcomes for Patients with HER2-Positive Early Breast Cancer Treated with CT-P6 or Reference Trastuzumab: Observational Follow-Up Study of a Phase 3 Randomised Controlled Trial

CT-P6 或参考曲妥珠单抗治疗 HER2 阳性早期乳腺癌患者的六年生存结果:一项 3 期随机对照试验的观察性随访研究

Stebbing, Justin; Baranau, Yauheni; Baryash, Valery; Moiseyenko, Vladimir; Boliukh, Dmytro; Antone, Nicoleta; Manikhas, Alexey; Chornobai, Anatolii; Park, Taehong; Baek, Eric Hyungseok; Lee, Jaeyong; Choi, Jiin; Kim, Nahyun; Ahn, Keumyoung; Lee, Sang Joon; Kim, Sunghyun

Changes in the concentration of EGFR-mutated plasma DNA in the first hours of targeted therapy allow the prediction of tumor response in patients with EGFR-driven lung cancer

靶向治疗开始后数小时内血浆中EGFR突变DNA浓度的变化可以预测EGFR驱动型肺癌患者的肿瘤反应。

Moiseyenko, Fedor V; Kuligina, Ekaterina S; Zhabina, Albina S; Belukhin, Sergey A; Laidus, Tatiana A; Martianov, Aleksandr S; Zagorodnev, Kirill A; Sokolova, Tatyana N; Chuinyshena, Svetlana A; Kholmatov, Maxim M; Artemieva, Elizaveta V; Stepanova, Ekaterina O; Shuginova, Tatiana N; Volkov, Nikita M; Yanus, Grigoriy A; Imyanitov, Evgeny N

Tumor irradiation may facilitate the detection of tumor-specific mutations in plasma

肿瘤照射可能有助于检测血浆中肿瘤特异性突变。

Kuligina, Ekaterina; Moiseyenko, Fedor; Belukhin, Sergey; Stepanova, Ekaterina; Zakharova, Maria; Chernobrivtseva, Vera; Aliev, Ikram; Sharabura, Tatiana; Moiseyenko, Vladimir; Aleksakhina, Svetlana; Laidus, Tatiana; Martianov, Aleksandr; Kholmatov, Maksim; Whitehead, Aldon; Yanus, Grigoriy; Imyanitov, Evgeny

Long-term efficacy and safety of CT-P6 versus trastuzumab in patients with HER2-positive early breast cancer: final results from a randomized phase III trial

CT-P6 与曲妥珠单抗治疗 HER2 阳性早期乳腺癌患者的长期疗效和安全性:一项随机 III 期试验的最终结果

Stebbing, Justin; Baranau, Yauheni V; Baryash, Valery; Manikhas, Alexey; Moiseyenko, Vladimir; Dzagnidze, Giorgi; Zhavrid, Edvard; Boliukh, Dmytro; Pikiel, Joanna; Eniu, Alexandru E; Li, Rubi K; Tiangco, Beatrice; Lee, Sang Joon; Kim, Sunghyun